P
NTUS

Pitcairn’s Natus Medical Inc NTUS Stock Holding History

Pitcairn’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,892
Closed -$286K – 631
2022
Q1 		$286K Sell
10,892
-55
-0.5% -$1.34K 0.02% 514
2021
Q4 		$260K Buy
10,947
+913
+9% +$22.5K 0.02% 559
2021
Q3 		$252K Buy
10,034
+319
+3% +$8.13K 0.02% 555
2021
Q2 		$253K Buy
+9,715
New +$264K 0.02% 543
2018
Q4 		– Sell
-8,803
Closed -$314K – 548
2018
Q3 		$314K Sell
8,803
-513
-6% -$18.1K 0.03% 394
2018
Q2 		$322K Sell
9,316
-487
-5% -$17.1K 0.03% 376
2018
Q1 		$330K Sell
9,803
-3,201
-25% -$101K 0.04% 348
2017
Q4 		$497K Buy
13,004
+110
+0.9% +$4.39K 0.05% 266
2017
Q3 		$484K Sell
12,894
-647
-5% -$22.8K 0.05% 255
2017
Q2 		$505K Buy
13,541
+2,845
+27% +$103K 0.06% 234
2017
Q1 		$419K Sell
10,696
-372
-3% -$14K 0.05% 281
2016
Q4 		$385K Buy
11,068
+2,867
+35% +$113K 0.05% 318
2016
Q3 		$323K Sell
8,201
-102
-1% -$4.07K 0.04% 350
2016
Q2 		$314K Sell
8,303
-28
-0.3% -$938 0.04% 330
2016
Q1 		$320K Buy
8,331
+1,177
+16% +$43.8K 0.04% 326
2015
Q4 		$344K Sell
7,154
-899
-11% -$41.6K 0.04% 308
2015
Q3 		$318K Sell
8,053
-1,233
-13% -$52.4K 0.04% 313
2015
Q2 		$395K Sell
9,286
-14,169
-60% -$565K 0.05% 305
2015
Q1 		$926K Sell
23,455
-1,745
-7% -$64.3K 0.1% 165
2014
Q4 		$909K Sell
25,200
-5,939
-19% -$200K 0.1% 162
2014
Q3 		$919K Buy
31,139
+731
+2% +$20.2K 0.1% 158
2014
Q2 		$765K Sell
30,408
-521
-2% -$12.9K 0.08% 187
2014
Q1 		$798K Buy
30,929
+1,024
+3% +$25.8K 0.09% 180
2013
Q4 		$673K Buy
29,905
+1,923
+7% +$37.1K 0.07% 201
2013
Q3 		$396K Buy
+27,982
New +$374K 0.05% 288

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pitcairn's NTUS Position: Q2 2022 in Review

Pitcairn sold out of Natus Medical Inc (NTUS) in Q2 2022, closing a stake of 10,892 shares — an estimated $286K sold.

Pitcairn first reported a position in NTUS in Q3 2013 and held it in 25 quarters. The position peaked at $926K in Q1 2015. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.

  • Pitcairn reported no remaining Natus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Pitcairn sold 10,892 Natus Medical Inc shares in Q2 2022, an estimated $286K.
  • Pitcairn first reported a position in Natus Medical Inc in Q3 2013 and held it in 25 quarters.
  • Pitcairn's Natus Medical Inc position peaked at $926K in Q1 2015.
  • 186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.

Based on Pitcairn's 13F filing for Q2 2022, filed 12 Aug 2022.